全文获取类型
收费全文 | 27838篇 |
免费 | 1465篇 |
国内免费 | 501篇 |
专业分类
耳鼻咽喉 | 181篇 |
儿科学 | 1390篇 |
妇产科学 | 1595篇 |
基础医学 | 3271篇 |
口腔科学 | 191篇 |
临床医学 | 1880篇 |
内科学 | 4222篇 |
皮肤病学 | 507篇 |
神经病学 | 3215篇 |
特种医学 | 454篇 |
外国民族医学 | 3篇 |
外科学 | 2933篇 |
综合类 | 3068篇 |
现状与发展 | 5篇 |
预防医学 | 2022篇 |
眼科学 | 161篇 |
药学 | 2828篇 |
13篇 | |
中国医学 | 827篇 |
肿瘤学 | 1038篇 |
出版年
2023年 | 270篇 |
2022年 | 534篇 |
2021年 | 858篇 |
2020年 | 750篇 |
2019年 | 697篇 |
2018年 | 689篇 |
2017年 | 781篇 |
2016年 | 749篇 |
2015年 | 724篇 |
2014年 | 1296篇 |
2013年 | 1774篇 |
2012年 | 1192篇 |
2011年 | 1504篇 |
2010年 | 1229篇 |
2009年 | 1177篇 |
2008年 | 1287篇 |
2007年 | 1278篇 |
2006年 | 1239篇 |
2005年 | 1073篇 |
2004年 | 902篇 |
2003年 | 854篇 |
2002年 | 751篇 |
2001年 | 626篇 |
2000年 | 619篇 |
1999年 | 513篇 |
1998年 | 422篇 |
1997年 | 462篇 |
1996年 | 437篇 |
1995年 | 387篇 |
1994年 | 388篇 |
1993年 | 346篇 |
1992年 | 350篇 |
1991年 | 339篇 |
1990年 | 348篇 |
1989年 | 268篇 |
1988年 | 227篇 |
1987年 | 197篇 |
1986年 | 232篇 |
1985年 | 303篇 |
1984年 | 270篇 |
1983年 | 167篇 |
1982年 | 229篇 |
1981年 | 189篇 |
1980年 | 156篇 |
1979年 | 149篇 |
1978年 | 135篇 |
1977年 | 96篇 |
1976年 | 86篇 |
1975年 | 62篇 |
1974年 | 55篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
多囊卵巢综合征(polycystic ovary syndrome,PCOS)是一种内分泌代谢紊乱综合征,临床表现高度异质性。肥胖是PCOS异质性临床表现之一,超过50%的PCOS患者超重或肥胖。肥胖型PCOS主要表现为高雄激素血症、中心型肥胖和糖脂代谢紊乱,非肥胖型PCOS主要表现为黄体生成激素(luteinizing hormone,LH)水平异常升高。尽管肥胖型和非肥胖型PCOS均存在内分泌代谢异常,然而肥胖可加重PCOS糖脂代谢紊乱;肥胖型PCOS还表现脂肪代谢的异常。综述肥胖型PCOS患者的临床特征、性激素水平、糖脂代谢特征,旨在为肥胖型和非肥胖型PCOS患者新的分型诊治提供参考。 相似文献
2.
3.
4.
目的:探讨甲状旁腺激素(PTH)对大鼠牵张成骨(DO)过程中ONC、OPN、C-FOS、COL1、VEGF、RUNX2、ALP基因表达的影响。方法30只雄性大鼠制备大鼠下颌骨DO模型。随机分5组,每组6只。第1组(只有牵张无PTH),术后8周取材,应用HE染色及微CT检测,以确定成骨情况。第2组(有牵张无PTH),第3组(有牵张有PTH),第4组(无牵张有PTH),第5组(对照组:无牵张无PTH)。2、3、4组及对照组术后1周取材,RT-PCR测定ONC、OPN、C-FOS、COL1、VEGF、RUNX2、ALP基因的表达。结果第1组,新骨形成,骨质充满牵张区,骨质连续,大鼠建模成功。RT-PCR检测结果显示,2、3、4组与对照组比较,OPN、COL1、RUNX2、ALP基因表达有明显提高(P<0.05),其中第3组最为明显。ONC、C-FOS、VEGF基因2、3、4组与对照组比较差异无统计学意义(P>0.05)。结论 PTH在 DO 过程中,间歇性给以 PTH的作用只有在牵张期发挥作用,其对 OPN、COL1、RUNX2、ALP基因表达能够获得理想的协同作用。 相似文献
5.
6.
7.
Sex estimation by various forensic anthropology approaches is a crucial factor for identification of human skeletal remains. However, inexpensive, uncomplicated and reliable methods are still required, especially in a remote crime scene and a high crime incidence area. Here, we examined 13 sacral parameters from 78 independent skeletons derived from deceases found in Central Thailand (male, n = 46; female, n = 32) using simple standard anthropometric techniques for sex allocation. Discriminant analysis exhibited that anterior-posterior diameter of S1 vertebra corpus (APS) is the most accurate sacral parameter for sex determination in our study with 82.1% of correct discrimination rate. The accuracy could be improved up to 97.4% when additional three sacral variables including the length of sacrum measured from the medial anterior-superior sacral promontory to the medial anterior-inferior S5 vertebra (ASL), alar index (ALI), and the maximum anterior breadth of sacrum measured across sacral alar (ABS) were computed together with APS. These encourage the use of sacral morphometrics for sex assessment of human sacrum remains in Central Thailand. However, further investigation with broadening sacral morphometric data across the country might provide a promising sex determination equation from a sacral skeleton for Thai population. 相似文献
8.
9.
Could non-HDL-cholesterol be a better marker of atherogenic dyslipidemia in obstructive sleep apnea?
《Sleep medicine》2021
Background/objectiveObstructive sleep apnea (OSA) is independently associated with dyslipidemia, a surrogate marker of atherosclerosis. Low-density lipoprotein (LDL)-cholesterol is accepted as a major independent risk factor for cardiovascular disease. However, non-high-density lipoprotein (HDL)-cholesterol is a better marker of atherogenic dyslipidemia and recommended as a target of lipid lowering therapy. We aimed to assess the prevalence of atherogenic dyslipidemia, and relationship between OSA severity and serum LDL-cholesterol and non-HDL cholesterol levels in OSA patients.MethodsWe retrospectively evaluated treatment naïve 2361 subjects admitted to the sleep laboratory of a university hospital for polysomnography. All subjects’ lipid profile including total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, and non-HDL-cholesterol were measured.ResultsOut of 2361 patients (mean age 49.6 ± 11.9 years; 68.9% male, apnea-hypopnea index 36.6 ± 28.4/h), 185 (7.8%) had no OSA and 2176 (92.2%) had OSA. Atherogenic dyslipidemia prevalence was high (57–66%) in OSA patients, and especially increased in severe OSA compared to other groups (p < 0.05). Though total and LDL-cholesterol did not differ between those with and without OSA, non-HDL-cholesterol (p = 0.020), and triglycerides (p = 0.001) were higher and HDL-cholesterol levels (p = 0.018) were lower in OSA patients than non-OSA. Non-HDL-cholesterol was significantly correlated with OSA severity (p < 0.001) and hypoxia parameters (p < 0.01), whereas LDL-cholesterol showed no correlation.ConclusionsAtherogenic dyslipidemia is highly prevalent and non-HDL-cholesterol levels are significantly increased, predominantly in severe OSA patients. Non-HDL-cholesterol but not LDL-cholesterol, is significantly correlated with OSA severity and hypoxia parameters. Therefore, it could be better to use non-HDL-cholesterol, which is a guideline recommended target of lipid therapy, as a marker of atherosclerotic cardiovascular risk in OSA patients. 相似文献
10.